Unfortunately, your browser is too old to work on this website. Please upgrade your browser
23 November 2020

Matt Hancock responds to positive results from Phase 3 trials of the Oxford/AstraZeneca vaccine

Summary

In an interview with Sky News, Health and Social Care Secretary Matt Hancock says that the positive efficacy data reported from Phase 3 studies of Oxford University and AstraZeneca's potential COVID-19 vaccine is 'really encouraging news'. He says that the Medicines and Healthcare products Regulatory Agency (MHRA) now needs to look at the data to check that the vaccine is safe and effective. But he says that the UK government has '100 million doses on order' and, if all goes well, the 'bulk of the roll-out' could be in the New Year [2021]. Hancock says that the 'homegrown vaccine' is 'easier to administer' than the Pfizer vaccine because it does not need to be stored at very low temperatures.

Source(s)

Sky News video – Matt Hancock interview